FIGURE 6.
STING‐IRF3 pathway in skin samples from patients with psoriasis and T2DM. (A, B) Protein levels of STING, p‐IRF3 in the skin tissue of patients were measured by immunohistochemistry (×200). Data are represented as means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Scale bars, 50 µm